Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 30;10(9):1430.
doi: 10.3390/vaccines10091430.

SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients

Maddalena Peghin  1 , Elena Graziano  1 , Paolo Antonio Grossi  1
Affiliations
Review

SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients

Maddalena Peghin et al. Vaccines (Basel). .

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has posed significant global challenges for solid organ transplant (SOT) recipients. Mortality rates of COVID-19 in this patient population remain high, despite new available therapeutic options and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination. Priority access to SARS-CoV-2 vaccination for waitlisted candidates and for SOT patients and their family members is recommended since the advantage from vaccination reduces the risk of COVID-19-related complications. However, immunogenicity and efficacy of COVID-19 vaccines are lower in waitlisted candidates and SOT recipients than in the general population. Routine systematic assessment of humoral and cellular immune responses after SARS-CoV-2 vaccination is controversial, although highly recommended for investigation and improvement of knowledge. SOT recipients should continue to adhere to preventive protective measures despite vaccination and may undergo passive antibody prophylaxis. This article seeks to provide an update on SARS-CoV-2 vaccination and preventive measures in SOT recipients based on existing literature and international guidelines.

Keywords: COVID-19; SARS-CoV-2; immunity; transplant; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Peghin M., Grossi P.A. COVID-19 positive donor for solid organ transplantation. J. Hepatol. 2022;22 doi: 10.1016/j.jhep.2022.06.021. - DOI - PMC - PubMed
    1. Aubert O., Yoo D., Zielinski D., Cozzi E., Cardillo M., Durr M., Dominguez-Gil B., Coll E., Da Silva M.I., Sallinen V., et al. COVID-19 pandemic and worldwide organ transplantation: A population-based study. Lancet Public Health. 2021;6:e709–e719. doi: 10.1016/S2468-2667(21)00200-0. - DOI - PMC - PubMed
    1. Grima A.A., Murison K.R., Simmons A.E., Tuite A.R., Fisman D.N. Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac412. - DOI - PMC - PubMed
    1. Nimmo A., Gardiner D., Ushiro-Lumb I., Ravanan R., Forsythe J.L.R. The Global Impact of COVID-19 on Solid Organ Transplantation: Two Years Into a Pandemic. Transplantation. 2022;106:1312–1329. doi: 10.1097/TP.0000000000004151. - DOI - PMC - PubMed
    1. Altarawneh H.N., Chemaitelly H., Ayoub H.H., Tang P., Hasan M.R., Yassine H.M., Al-Khatib H.A., Smatti M.K., Coyle P., Al-Kanaani Z., et al. Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. N. Engl. J. Med. 2022;387:21–34. doi: 10.1056/NEJMoa2203965. - DOI - PMC - PubMed

LinkOut - more resources